Fine Mark National Bank & Trust Harrow Health, Inc. Transaction History
Fine Mark National Bank & Trust
- $2.81 Billion
- Q4 2024
A detailed history of Fine Mark National Bank & Trust transactions in Harrow Health, Inc. stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 22,730 shares of HROW stock, worth $680,536. This represents 0.03% of its overall portfolio holdings.
Number of Shares
22,730
Previous 22,730
-0.0%
Holding current value
$680,536
Previous $1.02 Million
25.37%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.2MCall Options Held
844KPut Options Held
698K-
Opaleye Management Inc. Boston, MA3.99MShares$119 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$64.8 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$64.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$56.1 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$21.9 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $810M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...